Citation: | CHEN Ru-jing, ZHOU Lun-jiang, WU Xue-min, HUANG Xiao-feng, CHE Yong-liang, YAN Shan, WANG Chen-yan, WANG Long-bai, LIU Yu-tao, WEI Hong. Sequence Analysis on gB Gene from Pseudorabies Virus[J]. Fujian Journal of Agricultural Sciences, 2016, 30(11): 1139-1144. doi: 10.19303/j.issn.1008-0384.2016.11.001 |
[1] |
邓仕伟,汪勇,薛春芳.我国伪狂犬病流行现状及新特点[J].动物医学进展,2006,27(9):105-107. http://www.cnki.com.cn/Article/CJFDTOTAL-DYJZ200609027.htm
|
[2] |
李碧,朱玲,周远,等.伪狂犬病毒神经传导研究[J].病毒学报,2014,30(3):332-337. http://www.cnki.com.cn/Article/CJFDTOTAL-BDXB201403019.htm
|
[3] |
SZPARA M, TAFURI Y, PARSONS L, et al. A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses[J]. PLoS Pathog, 2011, 7(10):e1002282. doi: 10.1371/journal.ppat.1002282
|
[4] |
张青占.变异猪伪狂犬病毒的分离鉴定及生物学特性分析[D].北京:中国农业科学院,2013.
|
[5] |
OKAZAKI K. Proteolytic cleavage of glycoprotein B is dispensable for in vitro replication, but required for syncytium formation of pseudorabies virus[J]. J Gen Virol, 2007, 88(7):1859-1865. doi: 10.1099/vir.0.82610-0
|
[6] |
DORY D, RMOND M, BVEN V, et al. Pseudorabies virus glycoprotein B can be used to carry foot and mouth disease antigens in DNA vaccination of pigs[J]. Antiviral Res, 2009, 81(3):217-225. doi: 10.1016/j.antiviral.2008.11.005
|
[7] |
CURANOVIC D, ENQUIST L W. Virion-incorporated glycoprotein B mediates transneuronal spread of pseudorabies virus[J]. J Virol, 2009, 83(16):7796-7804. doi: 10.1128/JVI.00745-09
|
[8] |
彭金美,安同庆,赵鸿远,等.猪伪狂犬病病毒新流行株的分离鉴定及抗原差异性分析[J].中国预防兽医学报,2013,35(1):1-4. http://www.cnki.com.cn/Article/CJFDTOTAL-DAYZ201512005.htm
|
[9] |
AN T, PENG J, TIAN Z, et al. Pseudorabies virus variant in Bartha-K61-vaccinated pigs, China, 2012[J]. Emerg Infect Dis, 2013, 19(11):1749-1755. doi: 10.3201/eid1911.130177
|
[10] |
YE C, ZHANG Q, TIAN Z, et al. Genomic characterization of emergent pseudorabies virus in China reveals marked sequence divergence:Evidence for the existence of two major genotypes[J]. Virology, 2015, 483:32-43. doi: 10.1016/j.virol.2015.04.013
|
[11] |
LUO Y, LI N, CONG X, et al. Pathogenicity and genomic characterization of a pseudorabies virus variant isolated from Bartha-K61-vaccinated swine population in China[J]. Vet Microbiol, 2014, 174(1-2):107-115. doi: 10.1016/j.vetmic.2014.09.003
|
[12] |
TOMBACZ D, SHARON D, OLAH P, et al. Strain Kaplan of Pseudorabies virus genome sequenced by PacBio Single-Molecule real-time sequencing technology[J]. Genome Announc, 2014, 2(4):e00628-14. http://cn.bing.com/academic/profile?id=edb3ef6231a071683b5e56c7a1c26fae&encoded=0&v=paper_preview&mkt=zh-cn
|
[13] |
GRIMM KS, KLUPP BG, GRANZOW H, et al. Analysis of viral and cellular factors influencing herpesvirus-induced nuclear envelope breakdown[J]. J Virol, 2012, 86(12):6512-6521. doi: 10.1128/JVI.00068-12
|
[14] |
KOO H, BAE S, CHOI J, et al. Characterization and expression of the pseudorabies virus (NYJ strain) glycoproteins in Bombyx mori cells and larvae[J]. J Asia Pac Entomol, 2011, 14(1):107-117. doi: 10.1016/j.aspen.2010.08.002
|
[15] |
WANG C, YUAN J, QIN H, et al. A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China[J]. Vaccine, 2014, 32(27):3379-3385. doi: 10.1016/j.vaccine.2014.04.035
|
[16] |
GU Z, DONG J, WANG J, et al. A novel inactivated gE/gI deleted pseudorabies virus (PRV) vaccine completely protects pigs from an emerged variant PRV challenge[J]. Virus Res, 2015, 195:57-63. doi: 10.1016/j.virusres.2014.09.003
|
[17] |
ZHANG C, GUO L, JIA X, et al. Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets[J]. Vaccine, 2015, 33(21):2432-2437. doi: 10.1016/j.vaccine.2015.03.094
|
[18] |
HU R, ZHOU Q, SONG W, et al. Novel pseudorabies virus variant with defects in TK, gE and gI protects growing pigs against lethal challenge[J]. Vaccine, 2015, 33(43):5733-5740. doi: 10.1016/j.vaccine.2015.09.066
|
[19] |
WANG T, XIAO Y, YANG Q, et al. Construction of a gE-Deleted Pseudorabies Virus and Its Efficacy to the New-Emerging Variant PRV Challenge in the Form of Killed Vaccine[J]. Biomed Res Int, 2015, 2015:684945. http://cn.bing.com/academic/profile?id=770c6c6b4c9d801a946c3b0e28b41598&encoded=0&v=paper_preview&mkt=zh-cn
|
[20] |
CONG X, LEI J, XIA S, et al. Pathogenicity and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant in susceptible animals[J]. Vet Microbiol, 2016, 182:170-177. doi: 10.1016/j.vetmic.2015.11.022
|